Skip to main content
  • 108 Accesses

Summary

Over 300 P450s have been cloned and sequenced. A gene superfamily composed of at least 36 gene families has been described in 31 eukaryotes (including 11 mammalian and three plant species). Twelve families, made up of 22 subfamilies, exist in all mammals examined to date including 36 P450s identified in humans. Substrates for P450s represent a wide range of endogeneous and xenobiotic chemicals — including a large number of pharmacologically active drugs. Current areas of research on P450 focus on differences in protein structure related to the specificity of substrate structure for metabolism, the identify and response of specific transcriptional regulatory elements influencing the induction of individual P450s, the frequency of polymorphisms and their impact on drug metabolism and susceptibility to cancer, and the heterologous expression of functional P450s in systems that, can be applied to drug discovery and toxicity evaluation studies. The diversity of P450s and their versatility in the metabolism of drugs continues to challenge the pharmacologist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R et al. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA and Cell Biology 1993; 12: 1–51.

    Article  PubMed  CAS  Google Scholar 

  2. Boddupalli SS, Hasermann CA, Ravichandran KG, Lu JY, Goldsmith EJ, Deisenhofer J et al. Crystallization and preliminary x-ray diffraction analysis of P450terp and the hemoprotein domain of P450BM-3, enzymes belonging to two distinct classes of the cytochrome P450 superfamily. Proc. Natl. Acad. Sci. USA 1992; 89: 5567–5571.

    Article  PubMed  CAS  Google Scholar 

  3. Ravichandran KG, Boddupalli SS, Hasermann CA, Peterson JA, Deisenhofer J. Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450’s. Science 1993; 261: 731–736.

    Article  PubMed  CAS  Google Scholar 

  4. Tyndale R, Aoyama T, Broly F, Matsunaga T, Inaba T, Kalow W et al. Identification of a new variant CYP2D6 allele lacking the phenotype. Pharmacogenetics 1991; 1: 26–32.

    Article  PubMed  CAS  Google Scholar 

  5. Lindberg RL, Negishi M. Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue. Nature 1989; 339: 632–634.

    Article  PubMed  CAS  Google Scholar 

  6. Conney AH. Pharmacological implications of microsomal enzyme induction. Pharmacological Reviews 1967; 19: 317–366.

    PubMed  CAS  Google Scholar 

  7. Remmer H, Merker HJ. The effect of drugs on the formation of smooth endoplasmic reticulum and drug-metabolizing enzymes. Annals NY Acad. Sci. 1965; 123: 79–97.

    Article  CAS  Google Scholar 

  8. Reye H, Reisz-Porszasz S, Hankinson O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 1992; 256: 1193–1195.

    Article  Google Scholar 

  9. Burbach KM, Poland A, Bradfield CA. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. USA 1992; 89: 8185–8189.

    Article  PubMed  CAS  Google Scholar 

  10. Harper PA, Giannone JV, Okey AB, Denison MS. In vitro transformation of the human Ah receptor and its binding to a dioxin response element. Molecular Pharmacology 1992; 42: 603–612.

    PubMed  CAS  Google Scholar 

  11. Shet MS, Fisher CW, Holmans PL, Estabrook RW. Human cytochrome P450 3A4. Enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase. Proc. Natl. Acad. Sci. USA 1993; 90: 11748–11752.

    Article  PubMed  CAS  Google Scholar 

  12. Crespi CL, Gozalez FJ, Steimel DT, Turner TR, Gelboin HV, Penman BW et al. A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing. Chemical Research in Toxicology 1991; 4: 566–572.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Estabrook, R.W. (1995). The Proliferating P450s: Providers of Polysubstrate Pharmacology. In: Cuello, A.C., Collier, B. (eds) Pharmacological Sciences: Perspectives for Research and Therapy in the Late 1990s. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7218-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-7218-8_14

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-0348-7220-1

  • Online ISBN: 978-3-0348-7218-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics